Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today: Donate
Dr. Sabine Mai
Manitoba Institute of Cell Biology, Winnipeg, MB
The proposed study focuses on ependymoma, a childhood brain tumour. At diagnosis, it is not possible to know which child will respond to treatment and which child will recur, i.e. if prognosis is favourable or non-favourable. We have developed quantitative tools that may allow for the distinction of good and poor responders at diagnosis.
These tools involve three-dimensional (3D) imaging of telomeres. Telomeres are the ends of chromosomes; they protect the chromosomes from damage and prevent recombination and fusion with other chromosomes (Mai, 2010). Telomere dysfunction therefore is associated with genomic instability and found in many cancers (Mai and Garini, 2006; Mai, 2010).
The data obtained in this study are quantitatively measured, and the output is expected to be a 3D nuclear telomeric profile of each child’s tumour, indicative of favourable or non-favourable disease and will, in the near future, enable for the first time a choice for specific treatments for each child’s ependymoma.
Young children who have been affected by a brain tumour diagnosis, either personally or through someone close to them, can gain support and information with our children’s storybook, 'A Friend in Hope'. This colourful book tells the story of a little girl named Hope and her journey with a brain tumour through the eyes of her friend Danny. The story follows Hope’s journey to wellness and addresses medical procedures, symptoms such as hair loss, hospital stays as well as missing school and friendsLearn more
For Theresa Acchione Parkinson, it’s been 15 years since her father passed away from glioblastoma brain cancer. And while Theresa...Learn more
“I look better than ever!” – it’s a statement you might hear when someone is newly retired and finally has the time to workout and eat...Learn more